These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 656865)

  • 1. Norethisterone oenanthate as an injectable contraceptive: use of a modified dose schedule.
    Giwa-Osagie OF; Savage J; Newton JR
    Br Med J; 1978 Jun; 1(6128):1660-2. PubMed ID: 656865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of contraceptive efficacy of norethisterone oenanthate (200 mg) injectable contraceptive given every two or three monthly. Indian Council of Medical Research Task Force on Hormonal Contraception.
    Banerjee SK; Baweja R; Bhatt RV; Chatterjee A; Choudhury SD; Coyaji B; Engineer AD; Gogoi MP; Hingorani V; Kasturilal
    Contraception; 1984 Dec; 30(6):561-74. PubMed ID: 6397328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norethisterone oenanthate as an injectable contraceptive: a study of patients discontinuing treatment.
    Giwa-Osagie OF; Savage J; Newton JR
    Contraception; 1978 Nov; 18(5):517-26. PubMed ID: 729377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception.
    Draper BH; Morroni C; Hoffman M; Smit J; Beksinska M; Hapgood J; Van der Merwe L
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD005214. PubMed ID: 16856087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicentre phase III comparative study of two hormonal contraceptive preparations NET-OEN (50 mg) + E2 valerate (5 mg) given every month and NET-OEN (200 mg) given every 2 months as intramuscular injection--a report of 12-month study. Indian Council of Medical Research Task Force on Hormonal Contraception.
    Contraception; 1990 Aug; 42(2):179-90. PubMed ID: 1964885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effects.
    Sang GW; Shao QX; Ge RS; Ge JL; Chen JK; Song S; Fang KJ; He ML; Luo SY; Chen SF
    Contraception; 1995 Mar; 51(3):167-83. PubMed ID: 7621685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical trial of norethisterone oenanthate (Norigest) injected every two months.
    Howard G; Blair M; Chen JK; Fotherby K; Muggeridge J; Elder MG; Bye PG
    Contraception; 1982 Apr; 25(4):333-40. PubMed ID: 7049569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal discharge: a perceived side effect and minor reason for discontinuation in hormonal injectable users in South Africa.
    Beksinska ME; Rees HV
    Afr J Reprod Health; 2001 Dec; 5(3):84-8. PubMed ID: 12471932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norethisterone oenanthate as an injectable contraceptive in two treatment schedules in interval subjects.
    Gulati K; Mapa MK; Gupta AN; Singh PM; Devi PK
    Asia Oceania J Obstet Gynaecol; 1984 Sep; 10(3):281-6. PubMed ID: 6525083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with intramuscular norethisterone oenanthate as a contraceptive.
    Howard G; Blair M; Fotherby K; Howell R; Elder MG; Bye P
    J Obstet Gynaecol (Lahore); 1980; 1(1):53-8. PubMed ID: 12264797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICMR (Indian Council of Medical Research) Task Force on Hormonal Contraception. Return of fertility following discontinuation of an injectable contraceptive--norethisterone oenanthate (NET EN) 200mg dose. Council of Medical Research.
    Contraception; 1986 Dec; 34(6):573-82. PubMed ID: 3549141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long acting injectable hormonal contraceptives.
    Fraser IS
    Clin Reprod Fertil; 1982 Mar; 1(1):67-88. PubMed ID: 6226351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with injectable progestogen- only contraceptives at University of Ilorin teaching hospital: a five year review.
    Balogun OR; Raji HO
    Niger Postgrad Med J; 2009 Dec; 16(4):260-3. PubMed ID: 20037621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa.
    Smit J; McFadyen L; Zuma K; Preston-Whyte E
    Soc Sci Med; 2002 Nov; 55(9):1511-22. PubMed ID: 12297238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norethisterone levels in maternal serum and milk after intramuscular injection of norethisterone oenanthate as a contraceptive.
    Fotherby K; Towobola O; Muggeridge J; Elder MG
    Contraception; 1983 Nov; 28(5):405-11. PubMed ID: 6673900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indian Council of Medical Research. Task Force on Hormonal Contraception: Phase II randomized clinical trial with norethisterone oenanthate 50 mg alone and in combination with 5 mg or 2.5 mg of either estradiol valerate or cypionate as a monthly injectable contraceptive.
    Baweja R; Bhattacharya SK; Choudhury SD; Krishna U; Manuel M; Phillips FS; Datey S; Kumar S; Mehta S; Saxena NC
    Contraception; 1985 Oct; 32(4):383-94. PubMed ID: 3907967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestogen-only injectable contraceptive: experience of women in Osogbo, southwestern Nigeria.
    Adeyemi AS; Adekanle DA
    Ann Afr Med; 2012; 11(1):27-31. PubMed ID: 22199044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
    Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
    Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.